Skip to main content Back to Top
Advertisement

11/22/2019

Tuberculin

Reason for the Shortage

    • Par has Aplisol available.
    • Sanofi Pasteur has Tubersol available.

Available Products

    • Aplisol injection, Par Pharmaceuticals, 5 TU/0.1 mL, 1 mL multiple dose vial, NDC 42023-0104-01
    • Aplisol injection, Par Pharmaceuticals, 5 TU/0.1 mL, 5 mL multiple dose vial, NDC 42023-0104-05
    • Tubersol injection, Sanofi Pasteur, 5 TU/0.1 mL, 1 mL multiple dose vial, NDC 49281-0752-21
    • Tubersol injection, Sanofi Pasteur, 5 TU/0.1 mL, 5 mL multiple dose vial, NDC 49281-0752-22

Estimated Resupply Dates

    • All marketed presentations are available.

Implications for Patient Care

    • CDC has additional information regarding the anticipated tuberculin shortage as well as management strategies on their website at https://emergency.cdc.gov/han/han00420.asp. The supply interruption is estimated to begin in June 2019 and continue for approximately 3 to 10 months.

Updated

Updated November 22, 2019 by Anthony Trovato, PharmD, BCPS. Created June 12, 2019 by Megan Dryer, PharmD. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins